| Name | Title | Contact Details |
|---|---|---|
Scott LeHew |
Senior Professional Sales | Profile |
Jeff Colunga |
Director Supply Chain | Profile |
Doretta Mistras |
Chief Financial Officer | Profile |
Doretta Mistras |
Chief Financial Officer Elect (CFO | Profile |
Erin Kelley-Anderson |
Senior Director Global HR | Profile |
Optimizing drug development with innovative instruments & scientific expertise.
Seamlessly integrating patient-specific surgical planning and navigation, professional education and rehearsal experiences with incredible VR-empowered patient engagement capabilities
Allarity Therapeutics (Nasdaq: ALLR) is a clinical-stage precision medicine company actively advancing a pipeline of in-licensed oncology therapeutics for patients with difficult-to-treat cancers. The company is leveraging its proprietary, highly accurate Drug Response Predictor (DRP®) technology to refine patient selection and improve clinical outcomes. Publicly traded on NASDAQ, Allarity (ALLR) is headquartered in Cambridge, MA, while maintaining an R&D facility in Hoersholm, Denmark. Allarity is committed to enhancing patient outcomes through improved decision-making and personalized cancer care.
With one call, Pafford Medical Services facilitates every component of patient transport on both sides of the horizon.